Tourniquet versus epinephrine injection for fibroid removal surgery
Part of Women’s health & pregnancy clinical trials.
This trial compares two methods to reduce bleeding during minimally invasive surgery to remove fibroids (noncancerous growths) from the uterus. You'll receive either a temporary tourniquet (a band that temporarily stops blood flow) or an injection of epinephrine (adrenaline) around the fibroid, and doctors will measure which approach works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 45 years old
- You have symptomatic uterine fibroids (fibroids causing symptoms like heavy bleeding or pain) that need surgical removal
- You have between 1 and 3 fibroids, each measuring between 3 and 10 centimeters across
- Your hemoglobin (oxygen-carrying protein in blood) level is at least 10 g/dL
- You do not have bleeding disorders, uncontrolled high blood pressure, heart rhythm problems, or active pelvic infections
- You are willing to attend follow-up appointments and provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether temporarily clamping the main blood vessels to the uterus during laparoscopic fibroid removal can reduce blood loss. It is for women with up to four fibroids who are planning this type of surgery.
This trial compares two surgical techniques to reduce bleeding during surgery to remove fibroids (benign tumors) from the uterus. The goal is to find the safest, least-bloody approach for women who need this procedure.
This trial compares two medications (ergometrine and carbetocin) given during surgery to see which one is better at reducing bleeding while removing fibroids. Both drugs help the uterus contract to control blood loss.
This trial compares two injected medicines (terlipressin vs carbetocin) given into the uterus during open fibroid (myomectomy) surgery to see which one reduces blood loss and helps maintain hemoglobin. It may help patients by targeting lower bleeding during surgery.
This study tests whether a medicine called terlipressin, given before surgery to remove uterine fibroids (myomectomy), can help reduce bleeding during the operation. If you are eligible, you may receive terlipressin or a placebo (a dummy medication) to see if it makes your surgery safer.
This study tests if blocking blood flow to the uterus and ovaries during minimally invasive fibroid removal surgery helps reduce bleeding. It may be an option if you are having this type of surgery for large or numerous fibroids.
Hear when a new Laparoscopic Myomectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.